Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Discontinuation of bisphosphonate therapy correlated with ... translate to other populations of patients with cancer and metastatic bone disease? According to Cesar Migliorati, Professor of ...

Bone-strengthening drugs for cancer are now available. They can help treat cancer that has spread to the bones (bone ...

Zoledronic acid has several advantages over other bisphosphonates ... recommended zoledronic acid dose for the treatment of bone metastases is 4 mg by IV infusion, infused over no less than ...